ArticlePharmaceuticals (Basel, Switzerland)2026
Preclinical Pharmacological Evaluation of Sacituzumab Govitecan (IMMU-132) in TROP2-Positive Colorectal Liver Metastasis Models.
Weili Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.